Tofflon Science and Technology Group Co., Ltd. (300171.SZ) SHZ
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In CNY
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Employees
5417
First IPO Date
February 01, 2011
| Name | Title | Pay | Year Born |
| Xiaodong Zheng | Chairman & GM | 0 | 1964 |
| Zhao Guo Xing | R & D Director | 0 | 1979 |
| Hui Xing Tang | Deputy General Manager | 0 | 1963 |
| Jin Wang Zheng | Technology Director & Director | 0 | 1976 |
| Zhao Wei | Accounting Supervisor | 0 | N/A |
| Yan Wang | Deputy GM & Secretary of the Board of Directors | 0 | 1979 |
| Dehua Lu | Financial Director | 0 | 1981 |
Tofflon Science and Technology Group Co., Ltd., originally established in 1993 as Shanghai Tofflon Science and Technology Co., Ltd. and headquartered in Shanghai, China, serves as a global purveyor of sophisticated equipment for the pharmaceutical and biotechnology sectors. The company's diverse offerings encompass specialized machinery for injectable drug manufacturing, including automated systems for solution preparation, aseptic filling lines tailored for ampoules, vials, syringes, and powders, along with freeze dryers featuring automatic loading capabilities, barrier systems, and plastic packaging machines. Beyond equipment, Tofflon also supplies active pharmaceutical ingredients and provides essential quality control systems such as visual inspection, leak detection, and integrated combination units. Furthermore, Tofflon is a significant provider of bio-process equipment and comprehensive integrated systems. These solutions cover various stages, from medium and buffer preparation to cell/microbial cultivation, harvesting, diafiltration/ultrafiltration (DF/UF), purification, and final filling processes. The company also offers specialized laboratory services for lyophilization of injectables.